Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Hou, Dapeng ^a   Wang, Qiushi ^a   Jiang, Cuihua ^a   Tian, Cui ^a   Li, Huaqing ^a   Ji, Bo ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM DERIVATIVE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIDAZOLE DERIVATIVE; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MINOCYCLINE; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; SULTAMICILLIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; ARTICLE; CHINA; CONTROLLED STUDY; DRUG USE; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH PROGRAM; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; TERTIARY CARE CENTER; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; PRACTICE GUIDELINE; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; TIME;

ANTI-BACTERIAL AGENTS; CHINA; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84904338828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101447     Document Type: Article

References (21)

1. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr., et al. (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29: 245-252. (Pubitemid 29380178)
2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011.
3. Reynolds L, McKee M (2009) Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy 90: 32-36.
4. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ (2006) Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2: 6.
5. Wang H, Chen M, China Nosocomial Pathogens Resistance Surveillance Study Group (2005) Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn Microbiol Infect Dis 51: 201-208. (Pubitemid 40568765)
6. MacDougall C, Polk RE (2005) Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 18: 638-656. (Pubitemid 41504509)
7. Bassetti M, Di Biagio A, Rebesco B, Cenderello G, Amalfitano ME, et al. (2000) Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents 16: 295-299.
8. Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, et al. (2005) Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis 11: 912-920. (Pubitemid 40720853)
9. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, et al. (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66: 1223-1230.
10. World Health Organization Collaborating Centre for Drug Statistics Methodology Web site. Available: http://www.whocc.no/atcddd/.
11. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Wayne, PA.
12. Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD (2006) Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 34: 303-309. (Pubitemid 46001355)
13. Armstrong GL, Conn LA, Pinner RW (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA 281: 61-66. (Pubitemid 29025101)
14. Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A (2007) Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece. Int J Antimicrob Agents 30: 360-365. (Pubitemid 47361710)
15. Brown EM, Nathwani D (2005) Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55: 6-9. (Pubitemid 40192608)
16. Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME (2005) Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41: 149-158. (Pubitemid 40962494)
17. Mohr JF, Jones A, Ostrosky-Zeichner L, Wanger A, Tillotson G (2004) Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002. Int J Antimicrob Agents 24: 346-351. (Pubitemid 39369479)
18. Cook PP, Das TD, Gooch M, Catrou PG (2008) Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents. Infect Control Hosp Epidemiol 29: 716-722.
19. Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC (1999) Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 43: 424-427. (Pubitemid 29079192)
20. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34: 634-640.
21. Ochs MM, McCusker MP, Bains M, Hancock RE (1999) Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother 43: 1085-1090. (Pubitemid 29214729)